The 2011 Oncology Forum was held in Munich, Germany on October 22. The audience totaled 130 participants, comprised mainly of doctors and alternative practitioners.

One of the lecturers was Dr. Rupert Handgretinger, Oncologist, Professor of Haematology and Oncology in Paediatrics and General Paediatrics at the T?bingen University Hospital (Germany) and Medical Director of that department in the Clinic for Child and Adolescent Medicine.

Dr. Handgretinger talked about the effects of BioBran and the drug IL-2 for immune therapy. The participants were very interested and engaged in a dynamic discussion about the topic.

・

Copyright(C)2011 Daiwa Pharmaceutical Co.,Ltd. All rights reserved. | HOME >